References of "Servais, Sophie"
     in
Bookmark and Share    
See detailTh17 cells impact on xenogeneic graft-versus-host disease
Delens, Loïc ULiege; SERVAIS, Sophie ULiege; Ehx, Grégory ULiege et al

Poster (2017, May 24)

Detailed reference viewed: 16 (5 ULiège)
See detailXenogeneic graft-versus-host disease : Impact of Th17 cells
Delens, Loïc ULiege; SERVAIS, Sophie ULiege; Vrancken, Louise ULiege et al

Poster (2017, March 27)

Detailed reference viewed: 26 (8 ULiège)
See detailImpact of Th17 population on xenogeneic graft-versus-host disease
Delens, Loïc ULiege; SERVAIS, Sophie ULiege; Vrancken, Louise ULiege et al

Poster (2017, February)

Detailed reference viewed: 18 (6 ULiège)
Full Text
Peer Reviewed
See detailFocus sur les lymphocytes T dans la maladie du greffon contre l'hôte après allogreffe de cellules soucges hématopoïétiques: implications pour de nouvelles stratégies de prévention
Vrancken, L; Delens, Loïc ULiege; BEGUIN, Yves ULiege et al

in Oncol. Hematol. (2017), 11

Malgré les stratégies de prévention actuelles, la maladie du greffon contre l’hôte (greffe-versus-hôte, GVH) aiguë (GVHa) reste une complication sévère et fréquente de l’allogreffe de cellules souches ... [more ▼]

Malgré les stratégies de prévention actuelles, la maladie du greffon contre l’hôte (greffe-versus-hôte, GVH) aiguë (GVHa) reste une complication sévère et fréquente de l’allogreffe de cellules souches hématopoïétiques. Bien que la physiopathologie de celle-ci ne reste que partiellement élucidée à ce jour, il est classiquement admis que les lymphocytes T (LT) jouent un rôle important dans son processus biologique. Les progrès récents de l’immunologie des LT dans la GVHa ont permis de diversifier les pistes visant à prévenir la survenue de cette complication post-greffe. Plusieurs approches sont en cours d’exploration dans des essais cliniques avec des résultats encourageant tels que la manipulation ex vivo des LT avant leur transfert chez le patient afin de leur faire exprimer des gènes suicide, l’élimination in vivo des LT proliférant directement après la greffe, l’inhibition de l’activation des LT en interférant avec les voies de signalisation en aval du TCR ou celles induites par les cytokines, l’induction de l’anergie des LT en bloquant les signaux de costimulation, le blocage de l’adressage des LT vers les organes lymphoïdes secondaires et les tissus cibles, la promotion de l’immunotolérance par la perfusion de lymphocytes T régulateurs ou par l’utilisation d’agents favorisant leur différenciation et leurs fonctions in vivo et la modulation de l’expression génique des cellules immunitaires par des modulateurs épigénétiques. Outre la prévention de la GVHa, le défi des nouvelles stratégies consiste également à ne pas compromettre l’effet bénéfique de la greffe contre la tumeur ni la reconstitution des défenses anti-infectieuses. [less ▲]

Detailed reference viewed: 31 (10 ULiège)
Full Text
Peer Reviewed
See detailReconstitution of adaptive immunity after umbilical cord blood transplantation and clinical implication regarding risk of infections
SERVAIS, Sophie ULiege; Hannon, Muriel ULiege; Peffault de Latour, R. et al

in Stem Cell Invest. (2017), 4

In comparison with allogeneic stem cell transplantation (alloHSCT) with other stem cell sources, umbilical cord blood transplantation (UCBT) was traditionally associated with increased risk of infections ... [more ▼]

In comparison with allogeneic stem cell transplantation (alloHSCT) with other stem cell sources, umbilical cord blood transplantation (UCBT) was traditionally associated with increased risk of infections, particularly during the first 3 months after transplantation. Longitudinal studies of immune monitoring reported peculiar patterns of T- and B-cell recovery in the peripheral blood of UCB recipients during the first months post-transplantation. Overall, current data suggest delayed reconstitution of naive and memory CD4+ and CD8+ T-cell pools after UCBT. This is particularly true for adult recipients and for patients who received in vivo T-cell depleting approaches before the transplantation. Such delayed T-cell recovery may increase susceptibility of UCB recipients for developing opportunistic infections and viral reactivations. Regarding B-cell recovery, UCBT was associated with accelerated B-lymphopoiesis. Recent studies also reported evidence for faster functional memory B-cell recovery in UCB recipients. In this article, we briefly review T- and B-cell reconstitution after alloHSCT, with emphasis on peculiarities observed after UCBT. We further put these data in lines with risks of infections after UCBT. [less ▲]

Detailed reference viewed: 27 (3 ULiège)
See detailXenogeneic graft-versus-host disease: Impact of Th17 cells.
Delens, Loïc ULiege; SERVAIS, Sophie ULiege; Vrancken, Louise et al

Poster (2016, December 08)

Detailed reference viewed: 24 (8 ULiège)
See detailImpact des cellules Th17 sur la GVH xénogénique
Delens, Loïc ULiege; SERVAIS, Sophie ULiege; Ehx, Grégory ULiege et al

Conference (2016, November 18)

Detailed reference viewed: 9 (3 ULiège)
Full Text
Peer Reviewed
See detailAlterations of circulating lymphoid committed progenitor cellular metabolism after allogeneic stem cell transplantation in humans
GLAUZY; PEFFAULT DE LATOUR; ANDRE-SCHMUTZ et al

in Experimental Hematology (2016), 44(9), 811-816

Detailed reference viewed: 10 (0 ULiège)
Full Text
Peer Reviewed
See detailNovel approaches for preventing acute graftversus- host disease after allogeneic hematopoietic stem cell transplantation
SERVAIS, Sophie ULiege; BEGUIN, Yves ULiege; Delens, Loïc ULiege et al

in Expert Opinion on Investigational Drugs (2016), 9

Introduction Allogeneic hematopoietic stem cell transplantation (alloHSCT) offers potential curative treatment for a wide range of malignant and nonmalignant hematological disorders. However, its success ... [more ▼]

Introduction Allogeneic hematopoietic stem cell transplantation (alloHSCT) offers potential curative treatment for a wide range of malignant and nonmalignant hematological disorders. However, its success may be limited by post-transplant acute graft-versus-host disease (aGVHD), a systemic syndrome in which donor’s immune cells attack healthy tissues in the immunocompromised host. aGVHD is one of the main causes of morbidity and mortality after alloHSCT. Despite standard GVHD prophylaxis regimens, aGVHD still develops in approximately 40–60% of alloHSCT recipients. Areas covered In this review, after a brief summary of current knowledge on the pathogenesis of aGVHD, the authors review the current combination of a calcineurin inhibitor with an antimetabolite with or without added anti-thymocyte globulin (ATG) and emerging strategies for GVHD prevention. Expert opinion A new understanding of the involvement of cytokines, intracellular signaling pathways, epigenetics and immunoregulatory cells in GVHD pathogenesis will lead to new standards for aGVHD prophylaxis allowing better prevention of severe aGVHD without affecting graft-versus-tumor effects. [less ▲]

Detailed reference viewed: 104 (22 ULiège)
Full Text
Peer Reviewed
See detailResponse to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status.
SERVAIS, Sophie ULiege; DUMONTIER, Nicolas; BIARD, L. et al

in Clinical Microbiology and Infection (2016), 22(3), 2891-7

Detailed reference viewed: 10 (0 ULiège)
See detailSalt but not glucocorticoïds enhances Th17 differentiation from naïve T cells in vitro
Delens, Loïc ULiege; SERVAIS, Sophie ULiege; Vrancken, Louise et al

Poster (2016, January 29)

Detailed reference viewed: 37 (13 ULiège)
Full Text
Peer Reviewed
See detailMultipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
SERVAIS, Sophie ULiege; GREGOIRE, Céline ULiege; BARON, Frédéric ULiege et al

in Belgian Journal of Hematology (2016), 7

Steroid-refractory acute graft-versus-host disease is a severe complication after allogeneic stem cell transplantation. So far, its treatment remains very challenging since the current therapies do not ... [more ▼]

Steroid-refractory acute graft-versus-host disease is a severe complication after allogeneic stem cell transplantation. So far, its treatment remains very challenging since the current therapies do not offer significant benefits. Among the most recent approaches, multipotent mesenchymal stromal cell-based therapy has attracted great interest over the past decade. Here, we briefly reviewed the current knowledges about the immunomodulatory properties of multipotent mesenchymal stromal cells as well as results of preclinical and clinical studies having assessed their efficacy to modulate steroid-refractory acute graft-versus-host disease. [less ▲]

Detailed reference viewed: 40 (4 ULiège)
Full Text
Peer Reviewed
See detailErythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survival
JASPERS, Aurélie ULiege; Baron, Frédéric ULiege; SERVAIS, Sophie ULiege et al

in American Journal of Hematology (2015), 90(9), 197-199

Detailed reference viewed: 48 (9 ULiège)
Full Text
Peer Reviewed
See detailImmune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation following Flu-TBI versus TLI-ATG Conditioning
HANNON, Muriel ULiege; BEGUIN, Yves ULiege; Ehx, Grégory ULiege et al

in Clinical Cancer Research : An Official Journal of the American Association for Cancer Research (2015), 21(14), 3131-9

Purpose: A conditioning regimen for allogeneic hematopoietic cell transplantation (HCT) combining total lymphoid irradiation (TLI) plus anti-thymocyte globulin (ATG) has been develop to induce graft ... [more ▼]

Purpose: A conditioning regimen for allogeneic hematopoietic cell transplantation (HCT) combining total lymphoid irradiation (TLI) plus anti-thymocyte globulin (ATG) has been develop to induce graft-versus-tumor effects without graft-versus-host disease (GVHD). Experimental Design: We compared immune recovery in 53 patients included in a phase II randomized study comparing nonmyeloablative HCT following either fludarabine plus 2 Gy total body irradiation (TBI arm, n=28) or 8 Gy TLI plus anti-thymocyte globulin (TLI arm, n=25). Results: In comparison to TBI patients, TLI patients had a similarly low 6-month incidence of grade II-IV acute GVHD, a lower incidence of moderate/severe chronic GVHD (P=0.02), a higher incidence of CMV reactivation (P<0.001), and a higher incidence of relapse (P=0.01). While recovery of total CD8+ T cells was similar in the two groups, with median CD8+ T cell counts reaching the normal values 40-60 days after allo-HCT, TLI patients had lower percentages of naïve CD8 T cells. Median CD4+ T cell counts did not reach the lower limit of normal values the first year after allo-HCT in the two groups. Further, CD4+ T cell counts were significantly lower in TLI than in TBI patients the first 6 months after transplantation. Interestingly, while median absolute regulatory T cell (Treg) counts were comparable in TBI and TLI patients, Treg/naïve CD4+ T cell ratios were significantly higher in TLI than in TBI patients the 2 first years after transplantation. Conclusions: Immune recovery differs substantially between these two conditioning regimens possibly explaining the different clinical outcomes observed (NCT00603954). [less ▲]

Detailed reference viewed: 93 (18 ULiège)
Full Text
Peer Reviewed
See detailLong-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.
JASPERS, Aurélie ULiege; Baron, Frédéric ULiege; Maertens, Johan et al

in American Journal of Hematology (2015), 90(7), 133-4

Detailed reference viewed: 37 (7 ULiège)
Full Text
Peer Reviewed
See detailCircadian and circannual variations in cord blood hematopoietic cell composition
Servais, Sophie ULiege; BAUDOUX, Etienne ULiege; Brichard, B. et al

in Haematologica (2015), 100(1), 32-34

Detailed reference viewed: 35 (11 ULiège)
Full Text
Peer Reviewed
See detailImpact of graft source and composition on outcomes after allogeneic stem cell transplantation
SERVAIS, Sophie ULiege; Baron, Frédéric ULiege; BEGUIN, Yves ULiege

in Belgian Journal of Hematology (2015), 6(4), 162-168

Detailed reference viewed: 24 (4 ULiège)